Preclinical biotech developing protein therapies for rare calcification diseases.
Industry: Health Care
First Day Return: +9.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/02/2020 |
Offer Price | $16.00 |
Price Range $16.00 - $16.00 | |
Offer Shares (mm) | 7.0 |
Deal Size ($mm) | $112 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/23/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $112 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Boston, MA, United States |
Founded | 2015 |
Employees at IPO | 24 |
Website www.inozyme.com |